Huntington National Bank’s PROVECTUS BIOPHARMACEUTICALS, INC. (DE) PVCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 4320 |
|
|
2025
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 4287 |
|
|
2025
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 4249 |
|
|
2025
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 4279 |
|
|
2025
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 4311 |
|
|
2024
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 4286 |
|
|
2024
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 4271 |
|
|
2024
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 4201 |
|
|
2024
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 4068 |
|
|
2023
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 4013 |
|
|
2023
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 3957 |
|
|
2023
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 3871 |
|
|
2023
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 3703 |
|
|
2022
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 3631 |
|
|
2022
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 2695 |
|
|
2022
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 2698 |
|
|
2022
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 2624 |
|
|
2021
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 2551 |
|
|
2021
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 2276 |
|
|
2021
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 2165 |
|
|
2021
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 2055 |
|
|
2020
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 2033 |
|
|
2020
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 1978 |
|
|
2020
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 1992 |
|
|
2020
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 2086 |
|
|
2019
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 2099 |
|
|
2019
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 2004 |
|
|
2019
Q2 | $0 | Buy |
+1
| New | – | ﹤0.01% | 2035 |
|
|
2019
Q1 | – | Sell |
-1
| Closed | – | – | 2030 |
|
|
2018
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 2091 |
|
|
2018
Q3 | $0 | Buy |
+1
| New | – | ﹤0.01% | 2075 |
|
|
2017
Q1 | – | Sell |
-200
| Closed | – | – | 1500 |
|
|
2016
Q4 | $0 | Hold |
200
| – | – | ﹤0.01% | 1596 |
|
|
2016
Q3 | $0 | Sell |
200
-27,000
| -99% | -$5.89K | ﹤0.01% | 1640 |
|
|
2016
Q2 | $10K | Buy |
27,200
+27,000
| +13,500% | +$10.3K | ﹤0.01% | 1252 |
|
|
2016
Q1 | $0 | Hold |
200
| – | – | ﹤0.01% | 1907 |
|
|
2015
Q4 | $0 | Hold |
200
| – | – | ﹤0.01% | 1757 |
|
|
2015
Q3 | $0 | Hold |
200
| – | – | ﹤0.01% | 1851 |
|
|
2015
Q2 | $1K | Hold |
200
| – | – | ﹤0.01% | 1759 |
|
|
2015
Q1 | $0 | Hold |
200
| – | – | ﹤0.01% | 1819 |
|
|
2014
Q4 | $0 | Buy |
+200
| New | +$183 | ﹤0.01% | 1814 |
|
Other funds holding PVCT
HFBOT
WPA
ACM
AW
FS
Huntington National Bank's PVCT Position: Q1 2026 in Review
Huntington National Bank held its PROVECTUS BIOPHARMACEUTICALS, INC. (DE) (PVCT) position steady in Q1 2026 at 1 share worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #4320.
Huntington National Bank first reported a position in PVCT in Q4 2014 and has held it in 39 quarters since. The position peaked at $10K in Q2 2016. 6 funds tracked by Wall St. Rank hold PVCT as of Q1 2026.
- Huntington National Bank held 1 share of PROVECTUS BIOPHARMACEUTICALS, INC. (DE) worth $0 as of Q1 2026.
- Huntington National Bank left its PROVECTUS BIOPHARMACEUTICALS, INC. (DE) share count unchanged in Q1 2026.
- PROVECTUS BIOPHARMACEUTICALS, INC. (DE) made up ﹤0.01% of Huntington National Bank's portfolio in Q1 2026, its #4320 holding.
- Huntington National Bank first reported a position in PROVECTUS BIOPHARMACEUTICALS, INC. (DE) in Q4 2014 and has held it in 39 quarters since.
- Huntington National Bank's PROVECTUS BIOPHARMACEUTICALS, INC. (DE) position peaked at $10K in Q2 2016.
- 6 funds tracked by Wall St. Rank held PROVECTUS BIOPHARMACEUTICALS, INC. (DE) as of Q1 2026.
Based on Huntington National Bank's 13F filing for Q1 2026, filed 15 May 2026.